Skip to content
PubMed This is a summary of 86 peer-reviewed journal articles Updated
Neurology · CDKL5 Deficiency Disorder

CDKL5 Deficiency Disorder (CDD): A Patient Guide

At a Glance

CDKL5 deficiency disorder is a lifelong genetic condition marked by early, often hard-to-control seizures and developmental challenges, including low muscle tone, movement, vision, feeding, digestion, and sleep problems. Care aims to improve seizures, comfort, engagement, and quality of life.

CDKL5 Deficiency Disorder (CDD) is a rare, lifelong condition that fundamentally changes how the brain develops and communicates. It is classified as a developmental and epileptic encephalopathy (DEE), a term that describes a dual challenge: the underlying genetic variant itself causes developmental impairment by disrupting early brain growth, while frequent, intense seizure activity can place an additional burden on a child’s ability to learn and reach milestones [1]. Because the CDKL5 protein is important for building the connections that allow brain cells to talk to one another, reduced or altered protein function affects many systems in the body, making this a truly multisystem disorder [2].

Note: While this guide provides educational information, it is not a substitute for individualized medical advice. A printable seizure action plan and emergency contacts list should be created with your doctor, and you should never change or stop an anti-seizure medication without consulting your neurology team.

For most families, the journey with CDD begins with seizures that appear in the first few months of life. These seizures are typically refractory, meaning they do not respond well to standard medications and often require a combination of treatments to manage [3]. While the seizures are the most visible sign of the disorder, they exist alongside significant developmental delays and physical challenges. Most children with CDD experience low muscle tone, limited mobility, and Cortical Visual Impairment (CVI), a condition where the brain struggles to process what the eyes see [4][5].

Living with CDD also means managing a range of daily health concerns that happen “beyond the seizures.” Many children face persistent gastrointestinal issues, such as constipation and feeding difficulties, as well as significant sleep disturbances that can affect the entire family’s well-being [6][7]. Because these symptoms are so interconnected, effective care requires a holistic, multidisciplinary approach. This involves a team of specialists—including neurologists, gastroenterologists, and vision experts—working together to support the child’s nutrition, comfort, and sensory needs [8].

Treating CDD is a delicate balancing act. While the goal is to reduce seizures using both conventional anti-seizure medications and newer, targeted therapies like ganaxolone, the ultimate priority is always the child’s quality of life [9]. Success is measured not just by a lower seizure count, but by a child who is more alert, engaged, and comfortable in their daily life. As you navigate this diagnosis, remember that while the medical path is complex, the focus remains on supporting your child’s unique way of experiencing the world and celebrating every milestone they achieve [10].

Common questions in this guide

What is CDKL5 deficiency disorder?
CDKL5 deficiency disorder is a rare, lifelong genetic condition that changes how the brain develops and how brain cells communicate. It commonly causes seizures beginning in the first months of life along with developmental delays and challenges affecting movement, vision, feeding, sleep, and other body systems.
How does the encephalopathy part of CDD affect development?
In CDD, the genetic change can disrupt early brain development, while frequent seizures may add another burden to learning and reaching milestones. This is why developmental challenges can occur beyond the effects of individual seizures.
What symptoms can occur besides seizures in CDD?
Children with CDD may have developmental delays, low muscle tone, limited mobility, and cortical visual impairment, in which the brain has trouble interpreting what the eyes see. Constipation, feeding difficulties, and sleep disturbances are also common concerns.
Why are seizures in CDD often difficult to control?
CDD affects brain development, and seizures can be frequent and intense, so they may not respond well to a single standard medicine. A neurology team may use a combination of anti-seizure treatments and consider newer options such as ganaxolone; caregivers should not change or stop medicine without guidance.
What specialists should care for a child with CDD?
Care often includes a neurologist, gastroenterologist, and vision specialist working as a multidisciplinary team. This coordinated approach can address seizures as well as nutrition, comfort, sensory needs, and related daily health concerns.
How do doctors decide whether a CDD treatment is helping?
They look beyond seizure counts to whether the child is more alert, engaged, comfortable, and able to participate in daily life. Families and clinicians also weigh side effects against benefits and choose goals that matter most for the child’s quality of life.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How does the 'encephalopathy' part of my child's diagnosis influence their development differently than just the seizures alone?
  2. 2.What are the most important non-seizure symptoms we should begin monitoring right now?
  3. 3.Who will be the primary coordinator of our multidisciplinary team to ensure all our specialists are communicating?
  4. 4.How do we decide when a treatment's side effects are outweighing its benefits for my child's quality of life?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.

    Amin S, Monaghan M, Aledo-Serrano A, et al.

    Frontiers in neurology 2022; (13()):874695 doi:10.3389/fneur.2022.874695.

    PMID: 35795799
  2. 2

    Epilepsy-Related CDKL5 Deficiency Slows Synaptic Vesicle Endocytosis in Central Nerve Terminals.

    Kontaxi C, Ivanova D, Davenport EC, et al.

    The Journal of neuroscience : the official journal of the Society for Neuroscience 2023; (43(11)):2002-2020 doi:10.1523/JNEUROSCI.1537-22.2023.

    PMID: 36759195
  3. 3

    Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder.

    Fehr S, Wong K, Chin R, et al.

    Neurology 2016; (87(21)):2206-2213 doi:10.1212/WNL.0000000000003352.

    PMID: 27770071
  4. 4

    CDKL5 deficiency disorder and other infantile-onset genetic epilepsies.

    Daniels C, Greene C, Smith L, et al.

    Developmental medicine and child neurology 2024; (66(4)):456-468 doi:10.1111/dmcn.15747.

    PMID: 37771170
  5. 5

    CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.

    Demarest ST, Olson HE, Moss A, et al.

    Epilepsia 2019; (60(8)):1733-1742 doi:10.1111/epi.16285.

    PMID: 31313283
  6. 6

    The natural history of CDKL5 deficiency disorder into adulthood.

    Aledo-Serrano A, Lewis-Smith D, Leonard H, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.01.12.24318239.

    PMID: 39867409
  7. 7

    Long time polysomnographic sleep and breathing evaluations in children with CDKL5 deficiency disorder.

    Hagebeuk EEO, Smits A, de Weerd A

    Sleep medicine 2023; (103()):173-179 doi:10.1016/j.sleep.2023.02.003.

    PMID: 36812861
  8. 8

    Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.

    Amin S, Møller RS, Aledo-Serrano A, et al.

    Epilepsia open 2024; (9(3)):832-849 doi:10.1002/epi4.12914.

    PMID: 38450883
  9. 9

    Ganaxolone: A Review in Epileptic Seizures Associated with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder.

    Hoy SM

    Paediatric drugs 2025; (27(1)):111-118 doi:10.1007/s40272-024-00670-6.

    PMID: 39792341
  10. 10

    Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial.

    Downs J, Jacoby P, Specchio N, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2024; (51()):140-146 doi:10.1016/j.ejpn.2024.06.005.

    PMID: 38959712

This CDKL5 deficiency disorder guide is for informational purposes only and does not constitute medical advice. Consult your child’s neurology team before changing seizure medicines or making care decisions.

Get notified when new evidence is published on CDKL5-deficiency disorder.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.